Deutsche Bank AG Sells 15,994 Shares of Silicon Laboratories, Inc. $SLAB

Deutsche Bank AG lessened its holdings in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 30.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,822 shares of the semiconductor company's stock after selling 15,994 shares during the quarter. Deutsche Bank AG owned approximately 0.11% of Silicon Laboratories worth $4,032,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Wells Fargo & Company MN grew its holdings in shares of Silicon Laboratories by 10.8% during the fourth quarter. Wells Fargo & Company MN now owns 40,988 shares of the semiconductor company's stock worth $5,092,000 after buying an additional 3,996 shares during the last quarter. Bank of Montreal Can lifted its position in shares of Silicon Laboratories by 25.6% during the 4th quarter. Bank of Montreal Can now owns 4,474 shares of the semiconductor company's stock valued at $556,000 after acquiring an additional 911 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Silicon Laboratories during the 4th quarter valued at approximately $14,252,000. Barclays PLC lifted its position in shares of Silicon Laboratories by 22.8% during the 4th quarter. Barclays PLC now owns 86,648 shares of the semiconductor company's stock valued at $10,764,000 after acquiring an additional 16,080 shares during the period. Finally, Mariner LLC lifted its position in shares of Silicon Laboratories by 12.6% during the 4th quarter. Mariner LLC now owns 4,614 shares of the semiconductor company's stock valued at $573,000 after acquiring an additional 515 shares during the period.

Silicon Laboratories Price Performance

Shares of NASDAQ SLAB traded up $1.2650 during mid-day trading on Thursday, reaching $135.0250. 92,269 shares of the company traded hands, compared to its average volume of 405,929. The stock has a fifty day simple moving average of $139.07 and a 200-day simple moving average of $127.88. Silicon Laboratories, Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The firm has a market cap of $4.43 billion, a PE ratio of -41.93 and a beta of 1.48.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The company had revenue of $192.85 million during the quarter, compared to analysts' expectations of $192.57 million. During the same period in the prior year, the company earned ($0.56) earnings per share. The business's quarterly revenue was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, analysts predict that Silicon Laboratories, Inc. will post -0.97 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SLAB has been the subject of a number of recent research reports. Susquehanna raised their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 22nd. KeyCorp increased their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 8th. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Morgan Stanley cut their target price on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 6th. Finally, Barclays raised their price target on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 5th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.

Insider Activity

In other news, SVP Brandon Tolany sold 2,270 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $132.69, for a total transaction of $301,206.30. Following the transaction, the senior vice president directly owned 62,328 shares in the company, valued at approximately $8,270,302.32. This represents a 3.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company's stock.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.